Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice.
暂无分享,去创建一个
A. Holland | Julianne S. Greenberg | Marcia C. Javitt | Jason Katzen | Sara Michael | Agnes E. Holland | Julianne S Greenberg | M. Javitt | Jason B. Katzen | S. Michael
[1] D. Kopans. "Off Label" Use of FDA-Approved Devices and Digital Breast Tomosynthesis. , 2015, AJR. American journal of roentgenology.
[2] Tor D Tosteson,et al. Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. , 2007, AJR. American journal of roentgenology.
[3] Laurie L Fajardo,et al. Cancer cases from ACRIN digital mammographic imaging screening trial: radiologist analysis with use of a logistic regression model. , 2009, Radiology.
[4] Madhavi Raghu,et al. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. , 2013, Radiology.
[5] E. Halpern,et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. , 2013, Radiology.
[6] M. Javitt. Section editor's notebook. Breast density and breast cancer risk-eyes wide open. , 2015, AJR. American journal of roentgenology.
[7] Gisella Gennaro,et al. Digital breast tomosynthesis versus digital mammography: a clinical performance study , 2010, European Radiology.
[8] L. Hardesty. Issues to consider before implementing digital breast tomosynthesis into a breast imaging practice. , 2015, AJR. American journal of roentgenology.
[9] Andriy I. Bandos,et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. , 2013, Radiology.
[10] S. Ciatto,et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. , 2013, The Lancet. Oncology.
[11] Bonnie N Joe,et al. Breast density legislation: mandatory disclosure to patients, alternative screening, billing, reimbursement. , 2015, AJR. American journal of roentgenology.
[12] M. Javitt. Reply to "Supporting informed choice before screening mammography is the only ethical option". , 2014, AJR. American journal of roentgenology.
[13] E. Mendelson,et al. Training and standards for performance, interpretation, and structured reporting for supplemental breast cancer screening. , 2015, AJR. American journal of roentgenology.
[14] C A Kelsey,et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. , 1998, Radiology.
[15] Federica Zanca,et al. Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study. , 2012, Radiology.
[16] Anne Marie Murphy,et al. Beyond the mammography quality standards act: measuring the quality of breast cancer screening programs. , 2014, AJR. American journal of roentgenology.
[17] David Gur,et al. Digital breast tomosynthesis: observer performance study. , 2009, AJR. American journal of roentgenology.
[18] S. Rose,et al. Implementation of breast tomosynthesis in a routine screening practice: an observational study. , 2013, AJR. American journal of roentgenology.